A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma	Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, neoplasm, osteosarcoma, sarcoma	Not yet recruiting	Phase 1 / Phase 2	2022-10-21		NCT05590572

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chonnam National University	3
Peking University People's Hospital	269
Qilu Hospital of Shandong University	249
Ruijin Hospital	454
Second Affiliated Hospital, Zhejiang University, School of Medicine	561
Shanghai Jiao Tong University Affiliated Sixth People's Hospital	37

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Orthopaedic Surgery, Sixth People's Hospital, Shanghai Jiao Tong University,	Shanghai	China	1
Department of Orthopedic Surgery Chonnam National University	Donggu	South Korea	1
Peking University People's Hospital	Beijing	China	12
Qilu Hospital of Shandong University	Jinan	China	25
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine	Shanghai	China	6